AMA urges Supreme Court to overturn ruling upholding pay-for-delay deals.

American Medical News (2/11, Gallegos) reports that "the American Medical Association is among those weighing in on a U.S. Supreme Court case that could set an important precedent for how quickly patients can access generic versions of medications." According to the article, "the high court will hear arguments March 25 about so-called pay-for-delay deals, in which brand-name drugmakers pay generic companies to end patent litigation and delay the introduction of equivalent generics." The report adds, "in a Jan. 29 friend-of-the-court brief, the AMA urged the Supreme Court to overturn a ruling by the 11th U.S. Circuit Court of Appeals upholding such agreements."